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Abstract
Background: The World Health Organization (WHO) estimates that there is a global healthcare workforce shortage
of 7.2 million, which is predicted to grow to 12.9 million by 2035.
Globally, people are living longer with multiple co-morbidities and require increased access and use of medicines.
Pharmacists are a key component of the healthcare workforce, and in many countries, pharmacists are the most
accessible healthcare profession. This paper identifies key issues and current trends affecting the global pharmacy
workforce, in particular workforce distribution, country economic status, capacity, and workforce gender balance.
Methods: National professional pharmacy leadership bodies, together with other contacts for professional bodies,
regulatory bodies, and universities, were approached to provide country-level data on pharmacy workforce. A
descriptive and comparative analysis was conducted to assess each country’s pharmacy workforce.
Results: A total of 89 countries and territories responded to the survey. To standardise the capacity measure, an
analysis of the population density of pharmacists (per 10 000 population) was performed. The sample mean was 6
pharmacists per 10 000 population (n = 80). There is considerable variation between the surveyed countries/territories
ranging from 0.02 (Somalia) to 25.07 (Malta) pharmacists per 10 000 population. African nations have significantly fewer
pharmacists per capita. Pharmacist density correlates with gross national income (GNI) and health expenditure. The
majority of pharmacists are employed in community settings, followed by hospital, industry-related, academia, and
regulation. There is a greater proportion of females in the pharmacy workforce globally, with some WHO regions
showing female representation of more than 65 % with an increasing trend trajectory.
Conclusions: Pharmacy workforce capacity varies considerably between countries and regions and generally correlates
with population- and country-level economic indicators. Those countries and territories with lower economic indicators
tend to have fewer pharmacists and pharmacy technicians; this has implications for inequalities regarding access to
medicines and medicine expertise.
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Background
The global healthcare workforce is undergoing dramatic
changes with increasing national populations, longer life
expectancies, increasing healthcare costs, and rapidly
growing demands for health services and burden of
chronic diseases affecting both the scale and scope of
practice. The World Health Organization (WHO) esti-
mates that there is a global healthcare workforce short-
age of 7.2 million, which is predicted to grow to 12.9
million by 2035 [1]. Prior to this in September 2000, the
United Nations launched the Millennium Development
Goals (MDGs) to combat poverty, hunger, disease,
illiteracy, environmental degradation, and discrimination
against women by 2015 [2]. It soon became apparent
that the global health workforce crisis was one of the
greatest constraints in delivering the MDGs. In 2006, a
WHO report emphasised the need for direct investment
in the training of healthcare workers as well as more ef-
ficient use of their skills [3]. In the years following, fur-
ther reports have highlighted shortages in the healthcare
workforce and the effect on implementation of primary
care, efficient and equitable use of financial resources,
and expansion of health services [4, 5]. Without a doubt,
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this has focussed global attention on the sustainable evo-
lution of the provision of healthcare services.
Globally, people are living longer with multiple co-
morbidities and are requiring increased access and use
of medicines. Pharmacists are a key component of the
healthcare workforce, and in many countries, pharma-
cists are the most accessible healthcare profession. Phar-
macists play an important role in the delivery of
healthcare services since they are involved in community
and hospital environments, as well as academia, re-
search, and regulation. However, pharmacist workforce
shortages have been reported in all sectors [6]. Alongside
the increased demand for the global healthcare work-
force, the pharmacy profession itself is undergoing dy-
namic change with more of a focus on patient-centred
care, clinical decision-making on medicine use, and in-
terprofessional collaboration. Whilst pharmacists are
trusted and accessible healthcare professionals, it is im-
portant to monitor how the pharmacy workforce is
changing. These changes will affect the planning of the
delivery of healthcare services. There is an imperative to
understand the current trends in the global pharmacy
workforce and the implications of these trends on the
future supply of pharmacists. Only then can it be de-
cided how and what measures are required in order to
balance the demand versus supply of pharmacists to help
improve the global healthcare workforce.
The objective of this paper is to recognise the key is-
sues and current trends affecting the global pharmacy
workforce. In particular, a focus on workforce distribu-
tion, country economic status, capacity building, and
workforce gender balance. The survey was conducted by
the International Pharmaceutical Federation (FIP) Educa-
tion Initiative (FIPEd); the data has been validated with re-
spondents and shared with the WHO Human Resources
for Health. Future articles will explore the data collated on
pharmacy education and pharmacy technicians in more
depth.
Methods
The study was based on a survey of national agencies
(professional leadership bodies, health workforce regula-
tors, ministries) developed in collaboration with the FIP
Collaborating Centre, University College London School
of Pharmacy and the FIP Education Initiative (FIPEd).
The survey gave a background to the reasons for collect-
ing the data and was composed of 42 questions which
sought data relating to pharmacy education, workforce
(absolute numbers of pharmacists and pharmacy techni-
cians), and relevant regulations for both pharmacists and
pharmacy technicians and was available in English,
French, and Spanish. It was conducted by sending a
document version of the survey via email to contacts de-
rived from FIP and was conducted over the time period
2012–2013, with repeat follow-up for non-responders.
Responses were collated on an Excel® spreadsheet for
further analysis.
The analysis used multiple data sources including
national population- and country-level economic indi-
cators (as reported by the World Bank [7]). WHO re-
gional comparisons were obtained from information
on the WHO website. In summary, information about
pharmacy education, workforce, and regulations was
obtained via the data collection survey whereas sec-
ondary information, e.g. economic indicators and na-
tional populations were obtained online from the
official data sources described above.
The dataset was cleaned and checked with respon-
dents (who reported information about pharmacy educa-
tion, workforce numbers, and regulations) before being
prepared for analysis using SPSS Statistics v22. The stat-
istical methods used were descriptive (frequencies, cen-
tral tendencies) and regression (correlation and linear).
Limitations include a reliance on published data and sec-
ondary sources for some national data and an assumption
that the data uses head counts of licensed pharmacists
with no differentiation between part-time and full-time
workers (analysis was not conducted using whole or full-
time equivalents).
Statistical analysis was performed to assess the
workforce of each country’s pharmacist and pharmacy
technician workforce size and capacity standardised by
population, standardised density of pharmacies (hence
possible accessibility to medicines), associations with
country economic status, gender distribution of phar-
macists, and workforce distribution by pharmacy
sector.
Results
A total of 89 countries and territories responded to the
data collection survey. Table 1 shows national respond-
ent frequencies by WHO regions. The response rate is
shown for each WHO region against the percentage of
all WHO member states, for example, African countries
represented 25 % of respondents to the survey and
Table 1 Respondent frequencies by sample and WHO region
WHO region Respondents
in sample
Percent All available WHO
member states
Percent
Africa 19 21.4 46 23.7
Americas 8 9.0 35 18.0
Eastern
Mediterranean
6 6.7 22 11.3
Western Pacific 23 25.8 27 13.9
South East Asia 6 6.7 11 5.7
Europe 27 30.3 53 27.3
Total 89 100.0 194 100.0
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account for 23.7 % of all WHO member states. Due to
small workforce numbers related to the Pacific Island
Countries (PICs), these countries were aggregated into a
single PIC case entity for the analysis. The final usable
data after verification was 81 cases presented here. The
total case load represents around three quarters of the
current world population and around half of all United
Nations (UN) member states. The analysis presented
should be interpreted with the caveat that the data was
generalised at the country level (in that pharmacist dens-
ity correlated to national economic indicators) and based
on the best available validated data collated by the FIPEd
team.
Collectively, the countries in this sample represent
around 2.5 million pharmacists and 1.4 million phar-
macy technicians. Comparing the pharmacist and
pharmacy technician groups with country/territory
population, there are correlations (R2 = 0.36 P < 0.0001
and R2 = 0.45 P < 0.0001, respectively). African countries
tend to have a greater tendency for fewer pharmacists and
pharmacy technicians per country population.
To standardise the measure of pharmacists, an analysis
of the population density of pharmacists (per 10 000
population) was performed (Fig. 1). The sample mean
was 6.02 pharmacists per 10 000 population (n = 80).
There is considerable variation between the surveyed
countries/territories ranging from 0.02 (Somalia) to 25.07
(Malta) pharmacists per 10 000 population. African na-
tions have significantly fewer pharmacists per capita.
Through the comparative analysis of the pharmacist
and pharmacy (community-based premises) densities, it
is recognised that for all countries/territories involved in
this survey, there is a greater number of pharmacists in
contrast to pharmacies (Fig. 2). However, when compar-
ing by WHO region, differences emerge with the Africa
region which has more pharmacies than pharmacists
per capita. Additionally, some countries report more
pharmacies than pharmacists (Afghanistan, Bangladesh,
Bhutan, Burundi, India, Nepal, Pakistan, Somalia,
Vietnam).
There is a relationship between the economic status of
a country (measured by gross national income (GNI) per
capita), health expenditure per capita, and pharmacist
density. Pharmacist density correlates with GNI and
health expenditure (r = 0.48 P < 0.0001; r = 0.43 P < 0.0001,
respectively).
Mapping pharmacists per capita density with World
Bank classification shows the relationship of the workforce
with economic indicators (Fig. 3). There are demographic
similarities with the lower-middle and upper-middle cat-
egories but large differences between low-income and
high-income countries.
The majority of pharmacists are employed in commu-
nity pharmacy, followed by hospital, industry, research
and academia, and regulation (Fig. 4). The distribution
across sectors varies among countries though regional
trends can be seen. The survey revealed on average 55 %
of pharmacists worked in community pharmacies, 18 %
in hospitals, 10 % in industry, 5 % in research and aca-
demia, and 5 % in regulation. Less than 5 % of the total
pharmacist workforce in Africa is employed in the
pharmaceutical industry. Conversely, the Southeast
Fig. 1 The density of pharmacists (per 10 000 population) displayed by country in descending order
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Asian region shows the proportion of industrial-sector
employment of pharmacists is 30 %. The European region
has the highest proportion of the pharmacy workforce
working in the community settings.
There is a greater proportion of females in the
pharmacy workforce globally, with some WHO
regions displaying female representation of more
than 65 %. Overall, the survey shows consistent
trends that the number of female pharmacists enter-
ing the profession is increasing. However, at a coun-
try and WHO region level, this distribution is varied
(Fig. 5).
Fig. 2 The mean densities of pharmacists and pharmacies displayed by WHO region (mean density per 10 000 population)
Fig. 3 The mean densities of pharmacists and pharmacies displayed by World Bank economic classification (mean density per 10 000 population)
Bates et al. Human Resources for Health  (2016) 14:61 Page 4 of 7
Fig. 4 Proportions of pharmacist workforce (sector %) displayed by WHO region
Fig. 5 Proportion of pharmacist workforce displayed by gender and WHO region (%)
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Discussion
There is a wide variability in the pharmacist workforce
and in the supply of pharmacists globally between coun-
tries. Pharmacy workforce per capita varies considerably
between countries and regions and generally correlates
with the size of population. Globally, countries with
lower numbers of pharmacists per capita are likely to
have less access to medicines as well as provision of
pharmaceutical services and advice.
This study provides an assessment of the workforce
stock of pharmacists in the countries who responded to
the survey. It is not possible to draw full conclusions on
whether there is a sufficient supply of pharmacists with
the relevant competencies and skill mix. For those coun-
tries with low densities of pharmacists, it is possible that
there is a gap between the need for pharmacy services
and the actual supply of pharmacists. Demand indicators
based on disease burden/need for services would help
assess if gaps are present. Pharmacist density is not an
end in itself but a means to improve health. Absolute
numbers of pharmacists do not reflect the issue of part-
time workers and their proportion of the workforce. Nor
does density of pharmacists describe the productivity of
the workforce. There may also be differences in the
urban/rural distribution of pharmacists and other factors
may impact on a nation’s supply of pharmacists (e.g.
healthcare policies and systems) that are beyond the
scope of this paper.
Figure 2 raises the issue of whether there is appropri-
ate supervision of pharmaceutical services in those
countries that have more pharmacies (premises) than
pharmacists. Additionally, African countries in general
lack both pharmacies and pharmacists, which again has
implications for access to medicines due to lack of avail-
ability (and likely inequitable distribution) of access
points—as well as a skilled workforce to give pharma-
ceutical advice. Those countries with more pharmacies
than pharmacists may be using other staff, for example,
pharmacy technicians, pharmacy support workers,
nurses, or others as the workforce, and further research
is required to ascertain if this is the case.
The correlation between economic status of a country
(as measured by GNI per capita) and related health ex-
penditure per capita with pharmacist density implies
that expenditure on health and pharmacist availability
directly relate to economic development.
The results showed that there is a linear association
with standardised pharmacist numbers and World
Bank classification (Fig. 3). The gap increases between
pharmacists and pharmacies with economic income,
perhaps due to greater employment opportunities for
pharmacists in high-income countries. In addition, the
density of pharmacies is greater than that of pharma-
cists in low-income countries and territories, which
suggests difficulty in access to medicines in these
environments.
It is likely that the distribution of pharmacists by sec-
tor within all regions, with community pharmacy being
the largest, reflects the model of delivery of pharmaceut-
ical care and access to medicines in individual nations;
for most countries, community-based pharmaceutical
health services are the main form of provision with hos-
pitals providing more pharmaceutical specialist care
(Fig. 4). (A community pharmacy is defined as a phar-
macy providing access to medicines for a specific com-
munity (often retail premises). A hospital pharmacy is
one which is located in a hospital.)
The increase in the proportion of females in the work-
force suggests that pharmacy remains an attractive car-
eer for women. This may be due to evolving roles such
as increased patient-facing duties as well as greater flexi-
bility of career structures and breaks.
Conclusions
Analysing and monitoring the status of the pharmacy
workforce is important if workforce challenges are to be ad-
dressed and workforce risks mitigated. However, there is no
universal coverage of pharmacy workforce intelligence—
human resource information systems are still weak in
many countries, and the number of countries publishing
regular and consistent pharmacy workforce data is consid-
ered to be low.
Pharmacy workforce density varies considerably be-
tween countries and workforce regions and generally
correlates with population numbers and country-level
economic indicators. Those countries and territories
with lower economic indicators tend to have fewer phar-
macists and pharmacy technicians—this has implications
for inequalities in access to medicines and medicine ex-
pertise. Ongoing efforts are needed to ensure capacity
building of skilled medicine expertise to meet the
pharmaceutical needs of populations.
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